About
SIRNA, Biologics, Monoclonal Antibodies, Small Molecules
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalAntibodyBiotech
Team (3)
Clinical Trials (15)
View allTotal Trials
15
As Lead Sponsor
12
As Collaborator
3
Total Enrollment
7,893
By Phase
PHASE2: 8PHASE1: 4PHASE3: 2PHASE2/PHASE3: 1
By Status
COMPLETED: 11ACTIVE_NOT_RECRUITING: 2RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline15 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06650852Lead Sponsor
A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)
PHASE2Recruiting
250 participants
Started: Oct 31, 2024 · Completed: Jul 31, 2027
NCT06491563Lead Sponsor
Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and PEG-IFNα Treating Chronic Hepatitis B Virus (HBV) Infection (ENRICH)
PHASE2Active, not recruiting
150 participants
Started: Aug 6, 2024 · Completed: Jun 30, 2027
NCT06057012Lead Sponsor
A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)
PHASE2Completed
11 participants
Started: Sep 29, 2023 · Completed: Mar 13, 2024
NCT05970289Lead Sponsor
Investigate the Efficacy and Safety of BRII-835 (VIR-2218) and PEG-IFNα Combination Therapy in Chronic HBV Patients
PHASE2Active, not recruiting
86 participants
Started: Aug 22, 2023 · Completed: Feb 28, 2026
NCT05845840Lead Sponsor
A Study of BRII-297 in Healthy Adult Subjects
PHASE1Completed
41 participants
Started: May 15, 2023 · Completed: Jan 17, 2024
Locations (1)
Headquarters
San Mateo, CA, United States
Map
Loading map...